Ohio Public Employees Retirement System (OPERS)
BIO icon

Ohio Public Employees Retirement System (OPERS)’s Bio-Rad Laboratories Class A BIO Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.59M Sell
5,698
-166
-3% -$47.8K 0.01% 1157
2025
Q4 		$1.78M Sell
5,864
-279
-5% -$87.1K 0.01% 1146
2025
Q3 		$1.72M Sell
6,143
-164
-3% -$44.6K 0.01% 1171
2025
Q2 		$1.52M Buy
6,307
+218
+4% +$51.5K 0.01% 1207
2025
Q1 		$1.48M Sell
6,089
-642
-10% -$193K 0.01% 1193
2024
Q4 		$2.21M Buy
+6,731
New +$2.28M 0.01% 1083
2024
Q3 		– Sell
-7,576
Closed -$2.07M – 2265
2024
Q2 		$2.07M Sell
7,576
-486
-6% -$141K 0.01% 961
2024
Q1 		$2.79M Sell
8,062
-724
-8% -$238K 0.01% 859
2023
Q4 		$2.84M Buy
8,786
+72
+0.8% +$22.6K 0.01% 877
2023
Q3 		$3.12M Sell
8,714
-936
-10% -$361K 0.01% 798
2023
Q2 		$3.66M Sell
9,650
-1,109
-10% -$451K 0.01% 758
2023
Q1 		$5.15M Sell
10,759
-321
-3% -$150K 0.02% 607
2022
Q4 		$4.66M Sell
11,080
-3,711
-25% -$1.5M 0.02% 649
2022
Q3 		$6.17M Sell
14,791
-92
-0.6% -$45.9K 0.03% 524
2022
Q2 		$7.37M Sell
14,883
-593
-4% -$309K 0.03% 485
2022
Q1 		$8.72M Buy
15,476
+2,822
+22% +$1.7M 0.03% 505
2021
Q4 		$9.56M Sell
12,654
-771
-6% -$577K 0.03% 485
2021
Q3 		$10M Buy
13,425
+232
+2% +$174K 0.04% 470
2021
Q2 		$8.5M Buy
13,193
+227
+2% +$138K 0.03% 533
2021
Q1 		$7.41M Buy
12,966
+1,440
+12% +$853K 0.03% 536
2020
Q4 		$6.72M Buy
11,526
+2,273
+25% +$1.29M 0.03% 515
2020
Q3 		$4.77M Buy
9,253
+247
+3% +$125K 0.03% 522
2020
Q2 		$4.07M Sell
9,006
-2,835
-24% -$1.25M 0.02% 610
2020
Q1 		$4.15M Buy
11,841
+1,264
+12% +$465K 0.03% 525
2019
Q4 		$3.91M Sell
10,577
-3,255
-24% -$1.15M 0.02% 644
2019
Q3 		$4.6M Buy
13,832
+1,950
+16% +$636K 0.02% 590
2019
Q2 		$3.71M Buy
11,882
+599
+5% +$179K 0.02% 703
2019
Q1 		$3.45M Sell
11,283
-492
-4% -$133K 0.02% 744
2018
Q4 		$2.73M Sell
11,775
-4,538
-28% -$1.22M 0.02% 776
2018
Q3 		$5.11M Buy
16,313
+2,682
+20% +$832K 0.03% 629
2018
Q2 		$3.93M Buy
13,631
+246
+2% +$67.9K 0.02% 748
2018
Q1 		$3.35M Buy
13,385
+521
+4% +$133K 0.02% 785
2017
Q4 		$3.07M Sell
12,864
-6,433
-33% -$1.56M 0.02% 853
2017
Q3 		$4.29M Sell
19,297
-5,595
-22% -$1.26M 0.02% 692
2017
Q2 		$5.63M Sell
24,892
-7,080
-22% -$1.54M 0.03% 548
2017
Q1 		$6.37M Sell
31,972
-938
-3% -$181K 0.04% 489
2016
Q4 		$6.31M Buy
32,910
+4,106
+14% +$700K 0.04% 498
2016
Q3 		$4.72M Buy
28,804
+913
+3% +$139K 0.03% 568
2016
Q2 		$3.99M Sell
27,891
-27
-0.1% -$3.85K 0.03% 587
2016
Q1 		$3.82M Sell
27,918
-1,497
-5% -$197K 0.03% 581
2015
Q4 		$4.08M Sell
29,415
-1,001
-3% -$139K 0.03% 546
2015
Q3 		$4.08M Sell
30,416
-1,365
-4% -$196K 0.03% 578
2015
Q2 		$4.79M Sell
31,781
-3,976
-11% -$569K 0.03% 582
2015
Q1 		$4.83M Buy
35,757
+2,184
+7% +$271K 0.03% 559
2014
Q4 		$4.05M Buy
33,573
+821
+3% +$94.5K 0.02% 616
2014
Q3 		$3.71M Sell
32,752
-2,351
-7% -$279K 0.02% 649
2014
Q2 		$4.2M Buy
35,103
+257
+0.7% +$31.4K 0.02% 639
2014
Q1 		$4.46M Sell
34,846
-1,424
-4% -$183K 0.03% 580
2013
Q4 		$4.48M Buy
36,270
+1,916
+6% +$233K 0.02% 624
2013
Q3 		$4.04M Buy
34,354
+2,975
+9% +$351K 0.02% 682
2013
Q2 		$3.52M Buy
+31,379
New +$3.68M 0.02% 678

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s BIO Position: Q1 2026 in Review

Ohio Public Employees Retirement System (OPERS) reduced its Bio-Rad Laboratories Class A (BIO) stake by 2.8% in Q1 2026, selling an estimated $47.8K and leaving 5,698 shares worth $1.59M. The position accounts for 0.01% of the portfolio, ranked #1157.

Ohio Public Employees Retirement System (OPERS) first reported a position in BIO in Q2 2013 and has held it in 51 quarters since. The position peaked at $10M in Q3 2021. 391 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

  • Ohio Public Employees Retirement System (OPERS) held 5,698 shares of Bio-Rad Laboratories Class A worth $1.59M as of Q1 2026.
  • Ohio Public Employees Retirement System (OPERS) sold 166 Bio-Rad Laboratories Class A shares in Q1 2026, an estimated $47.8K.
  • Bio-Rad Laboratories Class A made up 0.01% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q1 2026, its #1157 holding.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 51 quarters since.
  • Ohio Public Employees Retirement System (OPERS)'s Bio-Rad Laboratories Class A position peaked at $10M in Q3 2021.
  • 391 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2026, filed 14 May 2026.